Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections
Kinal Bhatt, Arjola Agolli, M. Patel, et al.
Discoveries (2021) Vol. 9, Iss. 1, pp. e126-e126
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

COVID-19 and mucormycosis superinfection: the perfect storm
Jaffar A. Al‐Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 833-853
Open Access | Times Cited: 156
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ana Isabel Ribeiro, Alice Dias, Andréa Zille
ACS Applied Nano Materials (2022) Vol. 5, Iss. 3, pp. 3030-3064
Open Access | Times Cited: 141
COVID-19-associated opportunistic infections: a snapshot on the current reports
Amir Abdoli, Shahab Falahi, Azra Kenarkoohi
Clinical and Experimental Medicine (2021) Vol. 22, Iss. 3, pp. 327-346
Open Access | Times Cited: 129
COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic’s second wave in India
Jesil Mathew Aranjani, Atulya Manuel, Habeeb Ibrahim Abdul Razack, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 11, pp. e0009921-e0009921
Open Access | Times Cited: 106
COVID-19-associated mucormycosis: Case report and systematic review
Ahmet Dilek, Reşat Özaras, Şevket Özkaya, et al.
Travel Medicine and Infectious Disease (2021) Vol. 44, pp. 102148-102148
Open Access | Times Cited: 85
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
Maryam Roudbary, Sunil Kumar, Awanish Kumar, et al.
Journal of Fungi (2021) Vol. 7, Iss. 9, pp. 720-720
Open Access | Times Cited: 81
Diabetes Mellitus and COVID-19: Review Article
Mahmoud Nassar, Ahmed Daoud, Nso Nso, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 6, pp. 102268-102268
Open Access | Times Cited: 73
Long‐term side effects and lingering symptoms post COVID‐19 recovery
Mohammad Zarei, Deepanwita Bose, Masoud Nouri‐Vaskeh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 67
Structural basis for inhibition and regulation of a chitin synthase from Candida albicans
Zhenning Ren, Abhishek Chhetri, Ziqiang Guan, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 7, pp. 653-664
Open Access | Times Cited: 61
An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature
Athina Lavrentieva, Evangelos Kaimakamis, Vassileios Voutsas, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Contribution of Particulates to Airborne Disease Transmission and Severity: A Review
Hyunji Myung, Young Soo Joung
Environmental Science & Technology (2024) Vol. 58, Iss. 16, pp. 6846-6867
Closed Access | Times Cited: 12
Recent Advances in Electrochemical and Nanophotonic Biosensors for SARS-CoV-2 Detection
Yeon Kyung Lee, Hyun Seok Song
BioChip Journal (2024) Vol. 18, Iss. 2, pp. 171-185
Open Access | Times Cited: 7
Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes
Omer Sefvan Janjua, Muhammad Saad Shaikh, Muhammad Amber Fareed, et al.
Journal of Fungi (2021) Vol. 8, Iss. 1, pp. 44-44
Open Access | Times Cited: 43
Mucormycosis – An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19
Vivek P. Chavda, Vasso Apostolopoulos
Maturitas (2021) Vol. 154, pp. 58-61
Open Access | Times Cited: 42
Root Causes of Fungal Coinfections in COVID-19 Infected Patients
Arman Amin, Artin Vartanian, Nicole Poladian, et al.
Infectious Disease Reports (2021) Vol. 13, Iss. 4, pp. 1018-1035
Open Access | Times Cited: 41
Time to Conquer Fungal Infectious Diseases: Employing Nanoparticles as Powerful and Versatile Antifungal Nanosystems against a Wide Variety of Fungal Species
Ali Jangjou, Zahra Zareshahrabadi, Milad Abbasi, et al.
Sustainability (2022) Vol. 14, Iss. 19, pp. 12942-12942
Open Access | Times Cited: 36
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Madhavan Yasasve, Kadambari Vijay Sai, Dilip Kumar Shanmugam, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3620-3620
Open Access | Times Cited: 28
Healthcare-associated infections in Dutch hospitals during the COVID-19 pandemic
Janneke D. M. Verberk, Tjallie van der Kooi, Nynke A. Kampstra, et al.
Antimicrobial Resistance and Infection Control (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Fungal positivity seen in tertiary care hospital during COVID-19 pandemic
Ravinder Kaur, Deepti Rawat, Ashish William, et al.
Access Microbiology (2025) Vol. 7, Iss. 1
Open Access
Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1033-1048
Open Access | Times Cited: 37
Laboratory diagnosis of mucormycosis
Munesh Kumar Gupta, Kailash Kumar, Neeraj Dhameja, et al.
Journal of Family Medicine and Primary Care (2022) Vol. 11, Iss. 5, pp. 1664-1671
Open Access | Times Cited: 23
Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health
Haroldo César de Oliveira, Bárbara Tavares Bezerra, Márcio L. Rodrigues
ACS Bio & Med Chem Au (2022) Vol. 3, Iss. 2, pp. 137-146
Open Access | Times Cited: 23
The emerging significance of nanomedicine-based approaches to fighting COVID-19 variants of concern: A perspective on the nanotechnology’s role in COVID-19 diagnosis and treatment
Chandra Kant Singh, Kushneet Kaur Sodhi
Frontiers in Nanotechnology (2023) Vol. 4
Open Access | Times Cited: 12
Post-COVID-19 Fungal Infection in the Aged Population
Vivek P. Chavda, Toshika Mishra, Sathvika Kamaraj, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 555-555
Open Access | Times Cited: 12
New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis
Vinícius Augusto Campos Péret, Rúbia Castro Fernandes Melo Reis, Saulo Fehelberg Pinto Braga, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115436-115436
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top